Quantum-Si incorporated (QSI)
Market Cap | 198.37M |
Revenue (ttm) | 2.27M |
Net Income (ttm) | -89.93M |
Shares Out | 142.71M |
EPS (ttm) | -0.63 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 279,588,120 |
Open | 1.560 |
Previous Close | 0.633 |
Day's Range | 1.240 - 1.890 |
52-Week Range | 0.652 - 2.430 |
Beta | 2.93 |
Analysts | Buy |
Price Target | 2.50 (+79.86%) |
Earnings Date | Nov 12, 2024 |
About QSI
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company’s platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for QSI stock is "Buy." The 12-month stock price forecast is $2.5, which is an increase of 79.86% from the latest price.
News
Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis
On Wednesday, Quantum-Si Incorporated QSI stock traded over 100% higher after the protein sequencing company announced a collaboration with NVIDIA Corporation NVDA to develop its new proteomics platfo...
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (N...
Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop ...
Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform
BRANFORD, Conn. & BLOOMINGTON, Minn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™ and SkyWaterTechnology (NASDAQ: SKY...
Quantum-Si and Planet Innovation to Partner on Proteus™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and Planet Innovation today announced that they will pa...
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quan...
Quantum-Si Honored with Frost & Sullivan's 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has been awarded Frost & Sulliv...
Quantum-Si incorporated (QSI) Q3 2024 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Doug Farrell - VP, IR Jeffrey Hawkins - President & CEO Jeffry Keyes - CFO Conf...
Quantum-Si Reports Third Quarter 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the third quarter...
University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Si's Next-Gen Protein Sequencer™ Platinum®
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a newly released preprint publication o...
Quantum-Si to Participate in Upcoming Investment Conferences
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two up...
Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Company will host an Investor ...
Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced its attendance at the 2024 American Soc...
Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--QSI to report Q3 2024 Operating Results on 11/12/24.
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--QSI announces inducement grants.
Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024.
Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces proteomics webinar.
Liberate Bio Integrates Quantum-Si's Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based biote...
CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces promotions and appointment of CCO.
Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces promotions and appointment of CCO.
Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the 2...
Quantum-Si incorporated (QSI) Q2 2024 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI) Q2 2024 Earnings Call Transcript August 7, 2024 4:30 PM ET Company Participants Doug Farrell - VP, IR Jeff Hawkins - President and CEO Jeff Keyes - CFO Conference...
Quantum-Si Reports Second Quarter 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si reports Q2 2024 Operating Results.
Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to webcast presentation from the Canaccord 44th Annual Growth Conference.
Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to report second quarter 2024 operating results on Wednesday, August 7, 2024.